Skip to content
OpenCapital
Get started

Bio-Techne TECH Q4 2025 Annual earnings

Reported August 6, 2025 · Before market open

Revenue$317.0MBeat by $22.3MDiluted EPS$0.53Beat by $0.03
Revenue estimate$294.6M
EPS estimate$0.50

Next report

Aug 5, 2026 (in a month)
Revenue estimate$314.4M
EPS estimate$0.53

Financials

Q4 2025

Income statement

See full
Revenue$317.0M+3.5%
Gross profit$198.8M-2.2%

Balance sheet

See full
Cash & equivalents$162.2M+6.8%
Total debt$444.1M+5.8%
Total equity$1.9B-7.3%
Total assets$2.6B-5.4%

Cash flow

See full
Operating cash flow$98.2M+30.1%
CapEx$4.9M-72.8%
Free cash flow$93.3M+62.2%

Valuation & ratios

Q4 2025

Valuation

See full
Market cap$7.84B-30.5%
Enterprise value$8.12B-29.6%
P/S6.4×-3.3×

Profitability

See full
Gross margin64.8%-1.6pp
FCF margin21%+0.7pp

Returns & leverage

See full
Debt / equity0.2×0.0×
Current ratio3.5×-0.4×

Segments

By product

See full
Consumables$252.9M+2.9%
Service$29.6M+5.1%
Instruments$28.9M+6.7%
Royalty$5.5M+9.0%

By segment

See full
Protein Sciences$226.5M+5.8%
Diagnostics And Spatial Biology$89.7M—

Versus estimates

Revenue

Q3 2026$311.4MMiss by $4.7MQ2 2026$295.9MBeat by $5.4MQ1 2026$286.6MMiss by $4.8M
Q4 2025$317.0MBeat by $22.3M
Q3 2025$316.2MMiss by $9.3MQ2 2025$297.0MMiss by $20.5M

Diluted EPS

Q3 2026$0.53Miss by $0.02Q2 2026$0.46Beat by $0.03Q1 2026$0.42Miss by $0.00
Q4 2025$0.53Beat by $0.03
Q3 2025$0.56Beat by $0.05Q2 2025$0.42Beat by $0.03

Ask the moment Bio-Techne reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Bio-Techne report Q4 2025 earnings?
Bio-Techne (TECH) reported Q4 2025 earnings on August 6, 2025 before market open.
What were Bio-Techne's Q4 2025 revenue and EPS?
Bio-Techne reported revenue of $317.0M and diluted EPS of $0.53 for Q4 2025.
Did Bio-Techne beat estimates in Q4 2025?
Revenue beat the consensus estimate of $294.6M by $22.3M. EPS beat the consensus estimate of $0.50 by $0.03.
How did Bio-Techne's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.5% from $306.1M a year earlier and diluted EPS grew 8.2% from $0.49.
Where can I find Bio-Techne's Q4 2025 SEC filings?
You can read the 10-K periodic report (0001558370-25-011716) directly on SEC EDGAR. The filing index links above go to sec.gov.